Optimizing TACE for Hepatocellular Carcinoma: The Impact of Intra-Arterial Contrast Enhanced Ultrasound

Optimizing TACE for Hepatocellular Carcinoma: The Impact of Intra-Arterial Contrast Enhanced Ultrasound

Transarterial chemoembolization (TACE) is a well-established treatment for intermediate-stage hepatocellular carcinoma (HCC), shown through randomized trials to improve survival compared to supportive care in patients with large, unresectable tumors who are not candidates for liver transplantation o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Linda Galasso, Jacopo Iaccarino, Giorgio Esposto, Gabriele Giansanti, Irene Mignini, Raffaele Borriello, Gianpaolo Vidili, Antonio Gasbarrini, Maria Elena Ainora, Maria Assunta Zocco
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Diagnostics
Subjects:	transarterial chemoembolization (TACE) hepatocellular carcinoma (HCC) intra-arterial contrast-enhanced ultrasound (IA CEUS)
Online Access:	https://www.mdpi.com/2075-4418/15/11/1380
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients
by: Yunjie Zhang, et al.
Published: (2025-07-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Inter-reader agreement of RECIST and mRECIST criteria for assessing response to transarterial chemoembolization in hepatocellular carcinoma
by: Saeed Mohammadzadeh, et al.
Published: (2025-05-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Impact of Microparticle Transarterial Chemoembolization (mTACE) on myeloid‐derived suppressor cell subtypes in hepatocellular carcinoma: Clinical correlations and therapeutic implications
by: Yuanxun Yue, et al.
Published: (2024-09-01)

Multiparametric Ultrasound in the Differential Diagnosis of Soft Tissue Tumors: A Comprehensive Review
by: Fabrizio Termite, et al.
Published: (2025-07-01)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
by: Andrew M. Brown, et al.
Published: (2023-02-01)

Identifying Subgroup at High Risk of Transarterial Chemoembolization Failure Among Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
by: Edoardo Poli, et al.
Published: (2025-02-01)

Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial
by: Jie Li, et al.
Published: (2025-07-01)

Pressure Gradient-Driven Embolization b-TACE for HCC: Technical and Diagnostic Step-by-Step Procedural Guide and Literature Review
by: Bianca Rocco, et al.
Published: (2025-07-01)

Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation
by: Hongkun Tan, et al.
Published: (2025-06-01)

Application of Nanotechnology in TACE Treatment of Liver Cancer
by: Yao L, et al.
Published: (2025-08-01)

Development and Validation of a Radiomics Nomogram Based on Magnetic Resonance Imaging and Clinicoradiological Factors to Predict HCC TACE Refractoriness
by: Dong Y, et al.
Published: (2025-07-01)

A Transcriptomic Biomarker for Predicting the Response to TACE Correlates with the Tumor Microenvironment and Radiomics Features in Hepatocellular Carcinoma
by: Wang C, et al.
Published: (2024-11-01)

DCP as a biomarker for TACE efficacy in hepatocellular carcinoma
by: Hui Xie, et al.
Published: (2025-07-01)

Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
by: Yu J, et al.
Published: (2025-07-01)

Development of a Nomogram for Prognostic Prediction of Large Hepatocellular Carcinoma With HBV After TACE Combined Conversion Therapy
by: Xu W, et al.
Published: (2025-04-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study
by: Lu C, et al.
Published: (2025-07-01)

Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma
by: Xiaokai Zhang, et al.
Published: (2024-12-01)

Clinical efficacy of TACE using coil or gelatin sponge combined with targeted therapy in the treatment of giant hepatocellular carcinoma with arterioportal fistulas
by: Zhijuan Wu, et al.
Published: (2025-05-01)

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆
by: Dongdong Xia, et al.
Published: (2025-01-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
by: Dai Y, et al.
Published: (2025-07-01)

Application of intraluminal brachytherapy for malignant obstruction in the porta hepatis: a retrospective control study
by: Yi Zhang, et al.
Published: (2025-05-01)

The delaying effect of toripalimab on disease progression in patients with advanced hepatocellular carcinoma and changes in serum tumor markers
by: Zhuo Yin, et al.
Published: (2025-07-01)

Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin
by: Lu SY, et al.
Published: (2024-10-01)

The prognostic value of AST-lymphocyte ratio index in liver cancer patients treated with TACE: a systematic review and single-center retrospective study
by: Yali Tian, et al.
Published: (2025-05-01)

Prognostic impact of tace combined with sorafenib or lenvatinib followed by regorafenib in recurrent hepatocellular carcinoma after liver transplantation: a retrospective study
by: Zhao-dan Ye, et al.
Published: (2025-07-01)

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study
by: Liu J, et al.
Published: (2025-07-01)

Development and validation of nomogram including mutations in angiogenesis-related genes as risk factors for HCC patients treated with TACE
by: Wanqing Shen, et al.
Published: (2025-08-01)

The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis
by: Wei Zhang, et al.
Published: (2025-05-01)

Health Outcomes and Resource Consumption Analysis of Radioembolization with Y90 Glass Microspheres (TARE-Y90) Versus Transarterial Chemoembolization with Irinotecan (DEBIRI) in Patients with Liver Metastases from Colorectal Cancer in Spain
by: Juan José Ciampi-Dopazo, et al.
Published: (2025-03-01)

Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma
by: Qingqing Pang, et al.
Published: (2025-07-01)

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
by: Wu L, et al.
Published: (2025-01-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Retrospective Comparative Study to Assess the Safety and Efficacy of Transradial Arterial Access for Hepatic Tumor Embolizations: A Single Operator Experience
by: Ramanivas Sundareyan, et al.
Published: (2023-01-01)